SG10201505609YA - Use of a fermented soy extract as a prebiotic composition - Google Patents
Use of a fermented soy extract as a prebiotic compositionInfo
- Publication number
- SG10201505609YA SG10201505609YA SG10201505609YA SG10201505609YA SG10201505609YA SG 10201505609Y A SG10201505609Y A SG 10201505609YA SG 10201505609Y A SG10201505609Y A SG 10201505609YA SG 10201505609Y A SG10201505609Y A SG 10201505609YA SG 10201505609Y A SG10201505609Y A SG 10201505609YA
- Authority
- SG
- Singapore
- Prior art keywords
- prebiotic composition
- fermented soy
- soy extract
- extract
- fermented
- Prior art date
Links
- 235000013406 prebiotics Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36588710P | 2010-07-20 | 2010-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201505609YA true SG10201505609YA (en) | 2015-09-29 |
Family
ID=45496476
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201505609YA SG10201505609YA (en) | 2010-07-20 | 2011-07-20 | Use of a fermented soy extract as a prebiotic composition |
| SG2013003835A SG187554A1 (en) | 2010-07-20 | 2011-07-20 | Use of a fermented soy extract for manufacture of a prebiotic composition |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013003835A SG187554A1 (en) | 2010-07-20 | 2011-07-20 | Use of a fermented soy extract for manufacture of a prebiotic composition |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9259450B2 (fr) |
| EP (1) | EP2595641B1 (fr) |
| JP (1) | JP6005041B2 (fr) |
| KR (1) | KR101849424B1 (fr) |
| CN (1) | CN103079583B (fr) |
| BR (1) | BR112013001369B1 (fr) |
| CA (1) | CA2805319C (fr) |
| HK (1) | HK1180230A1 (fr) |
| MY (1) | MY170190A (fr) |
| SG (2) | SG10201505609YA (fr) |
| TW (1) | TWI552685B (fr) |
| WO (1) | WO2012009961A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6333509B2 (ja) * | 2012-06-22 | 2018-05-30 | 雪印メグミルク株式会社 | 還元された桂皮酸類縁化合物含有画分の製造方法 |
| JP6605319B2 (ja) * | 2015-12-17 | 2019-11-13 | 株式会社ダイワ | 乳酸菌含有加工食品の製造方法 |
| US10869923B2 (en) * | 2016-03-30 | 2020-12-22 | Microbio Co. Ltd. | Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60134386D1 (de) * | 2001-03-21 | 2008-07-24 | Microbio Co Ltd | Verfahren zur Hemmung von Krebswachstum mit einem fermentierten Soja- Extrakt |
| US20020182274A1 (en) * | 2001-03-21 | 2002-12-05 | Kung-Ming Lu | Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| US20040219237A1 (en) * | 2002-06-25 | 2004-11-04 | Kung-Ming Lu | Process of using fermented Glycine max (L.) extract for enhancing natural killer cell activity and inhibitory activities to GABA and glutamate receptor binding |
| EP1512407A1 (fr) * | 2003-09-02 | 2005-03-09 | Microbio Company, Ltd. | Utilisation d'un extrait fermenté de Glycine max (L.) pour |
| CA2470090A1 (fr) * | 2004-06-18 | 2005-12-18 | Bio-K Plus International Inc. | Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques |
| CA2690058A1 (fr) * | 2006-06-09 | 2007-12-13 | 9205-5961 Quebec Inc. | Compositions probiotiques derivees de produits laitiers et leurs utilisations |
| KR100926170B1 (ko) * | 2007-10-05 | 2009-11-10 | 정재수 | 엽산이 혼입된 대두 발효 고분자물질 및 이를 포함하는조성물 |
| CN101692876A (zh) | 2009-09-18 | 2010-04-14 | 姜波 | 仔猪饲料 |
-
2011
- 2011-07-20 TW TW100125667A patent/TWI552685B/zh active
- 2011-07-20 SG SG10201505609YA patent/SG10201505609YA/en unknown
- 2011-07-20 MY MYPI2013000197A patent/MY170190A/en unknown
- 2011-07-20 EP EP11809150.3A patent/EP2595641B1/fr active Active
- 2011-07-20 KR KR1020137003457A patent/KR101849424B1/ko active IP Right Grant
- 2011-07-20 SG SG2013003835A patent/SG187554A1/en unknown
- 2011-07-20 CA CA2805319A patent/CA2805319C/fr active Active
- 2011-07-20 US US13/186,956 patent/US9259450B2/en active Active
- 2011-07-20 CN CN201180034981.6A patent/CN103079583B/zh active Active
- 2011-07-20 WO PCT/CN2011/001188 patent/WO2012009961A1/fr active Application Filing
- 2011-07-20 JP JP2013519938A patent/JP6005041B2/ja active Active
- 2011-07-20 BR BR112013001369-9A patent/BR112013001369B1/pt active IP Right Grant
-
2013
- 2013-06-27 HK HK13107557.5A patent/HK1180230A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1180230A1 (en) | 2013-10-18 |
| BR112013001369B1 (pt) | 2022-03-22 |
| US9259450B2 (en) | 2016-02-16 |
| KR20130136434A (ko) | 2013-12-12 |
| EP2595641B1 (fr) | 2018-03-14 |
| CA2805319C (fr) | 2020-06-30 |
| JP6005041B2 (ja) | 2016-10-12 |
| WO2012009961A1 (fr) | 2012-01-26 |
| TW201218965A (en) | 2012-05-16 |
| US20120058104A1 (en) | 2012-03-08 |
| BR112013001369A2 (pt) | 2020-10-06 |
| SG187554A1 (en) | 2013-03-28 |
| CN103079583A (zh) | 2013-05-01 |
| MY170190A (en) | 2019-07-09 |
| TWI552685B (zh) | 2016-10-11 |
| CN103079583B (zh) | 2015-03-25 |
| KR101849424B1 (ko) | 2018-05-31 |
| EP2595641A4 (fr) | 2014-01-01 |
| CA2805319A1 (fr) | 2012-01-26 |
| EP2595641A1 (fr) | 2013-05-29 |
| JP2013535439A (ja) | 2013-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2482213B (en) | Improvements relating to cabinets | |
| ZA201209259B (en) | Uses and compositions | |
| GB201003924D0 (en) | Immunogenic composition | |
| EP2536756A4 (fr) | Compositions relatives a l'albumine serique humaine et leurs methodes d'utilisation | |
| EP2584897A4 (fr) | Compositions contenant du resvératrol et procédés d'utilisation | |
| GB201006096D0 (en) | Novel compositions and uses thereof | |
| EP2582664A4 (fr) | Phénylthioacétates, compositions et procédés d'application | |
| HK1178465A1 (en) | Composition for improving condition of skin | |
| HK1184181A1 (en) | POLYETHERAMINES, COMPOSITIONS INCLUDING POLYETHERAMINES, AND METHODS OF g MAKING | |
| HK1213594A1 (zh) | 免疫原性組合物及其用途 | |
| GB201011991D0 (en) | Improvements relating to valves | |
| EP2609931A4 (fr) | Composition immunogène | |
| EP2760910A4 (fr) | Composés contenant de l'oxétane et compositions à base de ceux-ci | |
| PT2785769E (pt) | Composição endurecedora de epóxi e composições derivadas | |
| HK1180230A1 (en) | Use of a fermented soy extract for manufacture of a prebiotic composition | |
| PL2407155T3 (pl) | Formulacje inekalcytolu | |
| GB201002303D0 (en) | Improvements relating to garments | |
| HK1178025A1 (en) | Extract of teas | |
| PL3097920T3 (pl) | Kompozycja medyczna zawierająca ekstrakt stauntonia hexaphylla | |
| EP2640418A4 (fr) | Compositions immunogènes | |
| LT2654770T (lt) | Tenekteplazės farmacinės kompozicijos | |
| PL2513060T3 (pl) | Krystaliczna postać α karbabenzopirydu | |
| HK1183207A1 (en) | Extract of teas | |
| HK1179120A1 (en) | Extract of teas | |
| ZA201301908B (en) | Immunogenic compositions |